LatchBio

LatchBio is a San Francisco-based bioinformatics cloud platform designed to accelerate scientific discovery by providing a no-code infrastructure layer for biotech researchers. By abstracting the complexities of cloud computing and data management, the platform enables scientists to execute powerful computational pipelines, store experimental data, and visualize results without requiring extensive software engineering expertise. The company serves a diverse user base ranging from academic researchers to large-scale pharmaceutical enterprises, positioning itself as a critical tool for modern R&D workflows. Founded in 2021 by a team of UC Berkeley dropouts, LatchBio has rapidly evolved from a niche tool for CRISPR research into a comprehensive data and compute agent for the life sciences. The platform supports a wide array of laboratory instruments and workflows, emphasizing reproducibility and compliance through its SOC-2 Type II and HIPAA-certified infrastructure. With a strong focus on integrating AI agents to automate the processing of complex biological data, LatchBio aims to become the foundational operating system for the biocomputing revolution.

To build and disseminate the data infrastructure for the biocomputing revolution.

• Named to Forbes 30 Under 30 in Healthcare
• SOC-2 Type II and HIPAA compliant platform
• Supports over 40 types of laboratory kits and instruments
• Raised $163 million in total funding to scale AI agents for biology
• Claims to reduce analysis costs by approximately 80% compared to traditional methods

Sources

• LatchBio Official Website
• Forbes Company Profile